397 related articles for article (PubMed ID: 24055690)
21. In vitro characterisation of terbutaline sulphate particles prepared by thermal ink-jet spray freeze drying.
Sharma G; Mueannoom W; Buanz AB; Taylor KM; Gaisford S
Int J Pharm; 2013 Apr; 447(1-2):165-70. PubMed ID: 23454848
[TBL] [Abstract][Full Text] [Related]
22. Excipient-free nanoporous microparticles of budesonide for pulmonary delivery.
Nolan LM; Tajber L; McDonald BF; Barham AS; Corrigan OI; Healy AM
Eur J Pharm Sci; 2009 Jul; 37(5):593-602. PubMed ID: 19463948
[TBL] [Abstract][Full Text] [Related]
23. Inulin-Ethylenediamine Coated SPIONs Magnetoplexes: A Promising Tool for Improving siRNA Delivery.
Licciardi M; Li Volsi A; Sardo C; Mauro N; Cavallaro G; Giammona G
Pharm Res; 2015 Nov; 32(11):3674-87. PubMed ID: 26085039
[TBL] [Abstract][Full Text] [Related]
24. Inulin-based polymer coated SPIONs as potential drug delivery systems for targeted cancer therapy.
Scialabba C; Licciardi M; Mauro N; Rocco F; Ceruti M; Giammona G
Eur J Pharm Biopharm; 2014 Nov; 88(3):695-705. PubMed ID: 25281781
[TBL] [Abstract][Full Text] [Related]
25. Steroid/mucokinetic hybrid nanoporous microparticles for pulmonary drug delivery.
Tewes F; Paluch KJ; Tajber L; Gulati K; Kalantri D; Ehrhardt C; Healy AM
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):604-13. PubMed ID: 23563102
[TBL] [Abstract][Full Text] [Related]
26. Potential of aerosolized rifampicin lipospheres for modulation of pulmonary pharmacokinetics and bio-distribution.
Singh C; Koduri LV; Dhawale V; Bhatt TD; Kumar R; Grover V; Tikoo K; Suresh S
Int J Pharm; 2015 Nov; 495(2):627-32. PubMed ID: 26392246
[TBL] [Abstract][Full Text] [Related]
27. Development and characterisation of soluble polymeric particles for pulmonary peptide delivery.
Tewes F; Tajber L; Corrigan OI; Ehrhardt C; Healy AM
Eur J Pharm Sci; 2010 Oct; 41(2):337-52. PubMed ID: 20621184
[TBL] [Abstract][Full Text] [Related]
28. Physicochemical characterization of nebulized superparamagnetic iron oxide nanoparticles (SPIONs).
Graczyk H; Bryan LC; Lewinski N; Suarez G; Coullerez G; Bowen P; Riediker M
J Aerosol Med Pulm Drug Deliv; 2015 Feb; 28(1):43-51. PubMed ID: 24801912
[TBL] [Abstract][Full Text] [Related]
29. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.
Laurent S; Saei AA; Behzadi S; Panahifar A; Mahmoudi M
Expert Opin Drug Deliv; 2014 Sep; 11(9):1449-70. PubMed ID: 24870351
[TBL] [Abstract][Full Text] [Related]
30. Effect of magnesium stearate surface coating method on the aerosol performance and permeability of micronized fluticasone propionate.
Kumar V; Sethi B; Yanez E; Leung DH; Ghanwatkar YY; Cheong J; Tso J; Narang AS; Nagapudi K; Mahato RI
Int J Pharm; 2022 Mar; 615():121470. PubMed ID: 35041913
[TBL] [Abstract][Full Text] [Related]
31. Pegylated magnetic nanocarriers for doxorubicin delivery: a quantitative determination of stealthiness in vitro and in vivo.
Allard-Vannier E; Cohen-Jonathan S; Gautier J; Hervé-Aubert K; Munnier E; Soucé M; Legras P; Passirani C; Chourpa I
Eur J Pharm Biopharm; 2012 Aug; 81(3):498-505. PubMed ID: 22510695
[TBL] [Abstract][Full Text] [Related]
32. Dry powder aerosol delivery of large hollow nanoparticulate aggregates as prospective carriers of nanoparticulate drugs: effects of phospholipids.
Hadinoto K; Phanapavudhikul P; Kewu Z; Tan RB
Int J Pharm; 2007 Mar; 333(1-2):187-98. PubMed ID: 17084567
[TBL] [Abstract][Full Text] [Related]
33. Formulation of a novel fixed dose combination of salmeterol xinafoate and mometasone furoate for inhaled drug delivery.
Liu S; Watts AB; Du J; Bui A; Hengsawas S; Peters JI; Williams RO
Eur J Pharm Biopharm; 2015 Oct; 96():132-42. PubMed ID: 26220015
[TBL] [Abstract][Full Text] [Related]
34. Development of low density azithromycin-loaded polycaprolactone microparticles for pulmonary delivery.
Kasten G; Silva LF; Lemos-Senna E
Drug Dev Ind Pharm; 2016 May; 42(5):776-787. PubMed ID: 26266961
[TBL] [Abstract][Full Text] [Related]
35. Preparation and Characterization of Doripenem-Loaded Microparticles for Pulmonary Delivery.
Yildiz-Peköz A; Akbal O; Tekarslan SH; Sagirli AO; Mulazimoglu L; Morina D; Cevher E
J Aerosol Med Pulm Drug Deliv; 2018 Dec; 31(6):347-357. PubMed ID: 29877747
[No Abstract] [Full Text] [Related]
36. Formulation and in vivo evaluation of effervescent inhalable carrier particles for pulmonary delivery of nanoparticles.
Azarmi S; Lobenberg R; Roa WH; Tai S; Finlay WH
Drug Dev Ind Pharm; 2008 Sep; 34(9):943-7. PubMed ID: 18800255
[TBL] [Abstract][Full Text] [Related]
37. Dexamethasone acetate encapsulation into Trojan particles.
Gómez-Gaete C; Fattal E; Silva L; Besnard M; Tsapis N
J Control Release; 2008 May; 128(1):41-9. PubMed ID: 18374442
[TBL] [Abstract][Full Text] [Related]
38. Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery.
Li X; Vogt FG; Hayes D; Mansour HM
Eur J Pharm Sci; 2014 Feb; 52():191-205. PubMed ID: 24215736
[TBL] [Abstract][Full Text] [Related]
39. Formulation, stability and pharmacokinetics of sugar-based salmon calcitonin-loaded nanoporous/nanoparticulate microparticles (NPMPs) for inhalation.
Amaro MI; Tewes F; Gobbo O; Tajber L; Corrigan OI; Ehrhardt C; Healy AM
Int J Pharm; 2015 Apr; 483(1-2):6-18. PubMed ID: 25660067
[TBL] [Abstract][Full Text] [Related]
40. Swellable microparticles as carriers for sustained pulmonary drug delivery.
El-Sherbiny IM; McGill S; Smyth HD
J Pharm Sci; 2010 May; 99(5):2343-56. PubMed ID: 19967777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
